This company seems to have been delisted
Reason: Merged with Ayala Pharmaceuticals
Source: https://ir.ayalapharma.com/news-releases/news-release-details/advaxis-and-ayala-pharmaceuticals-complete-merger
Reason: Merged with Ayala Pharmaceuticals
Source: https://ir.ayalapharma.com/news-releases/news-release-details/advaxis-and-ayala-pharmaceuticals-complete-merger
Advaxis
ADXS
$0.03000
Share price
0.00%
Change (1 day)
-94.92%
Change (1 year)
Categories
Earnings for Advaxis (ADXS)
Earnings in 2023 (TTM): -$34.03 Million USD
According to Advaxis's latest financial reports the company's current earnings are $0.11 Million USD. In 2022 the company made an earning of -$37.44 Million USD, an increase over its 2021 earnings that were of -$39.22 Million USD. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Advaxis from 2019 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$34.03 Million | -9.13% |
| 2022 | -$37.44 Million | -4.53% |
| 2021 | -$39.22 Million | 31.71% |
| 2020 | -$29.78 Million | 68.13% |
| 2019 | -$17.72 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -$0.11 Billion | 214.72% | 🇺🇸 USA |
 | -$37.2 Million | 9.31% | 🇺🇸 USA |
 | -$18.34 Million | -46.11% | 🇺🇸 USA |